Total Raised

$4M

Investors Count

2

Deal Terms

1

Funding, Valuation & Revenue

2 Fundings

SmartZyme has raised $4M over 2 rounds.

SmartZyme's latest funding round was a Series B for on March 14, 2018.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

3/14/2018

Series B

$XXM

0

FY undefined

1

10/27/2015

Series A

$XXM

$XXM

0

FY undefined

10

Date

3/14/2018

10/27/2015

Round

Series B

Series A

Amount

$XXM

Investors

Valuation

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

Sources

1

10

Start free trial
New call-to-action

SmartZyme Deal Terms

1 Deal Term

SmartZyme's deal structure is available for 1 funding round, including their Series A from October 27, 2015.

Round

Series A

Funding Date

$XXM

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

Board Voting

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series A

$XXM

$XXM

$XXM

$XXM

SmartZyme Investors

2 Investors

SmartZyme has 2 investors. OrbiMed invested in SmartZyme's Series B funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

10/27/2015

3/14/2018

2
Series A, Series B (2018)

Venture Capital

New York

00/00/0000

00/00/0000

Virtus Inspire Ventures

Subscribe to see more

Venture Capital

Hong Kong

First funding

10/27/2015

00/00/0000

Last Funding

3/14/2018

00/00/0000

Investor

Virtus Inspire Ventures

Rounds

2
Series A, Series B (2018)

Subscribe to see more

Board Seats

Type

Venture Capital

Venture Capital

Location

New York

Hong Kong

New call-to-action

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.